Nursing

Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals

NES-ZIONA, ISRAEL / ACCESSWIRE / February 21, 2024 / Mike Williams made a name for himself making difficult endzone catches...

Serving Patients and Communities Through Comprehensive Care Solutions: OSF HealthCare, Pointcore, Inc. and GE HealthCare Enter Strategic Care Alliance

10-year collaboration aims to expand the reach of innovative technology and digital solutions to more than one million patients. CHICAGO--(BUSINESS...

Digital Divide Widens for Financially Strained Small Hospitals, Black Book Annual Survey of Critical Access and Rural Facility Administrators

The operating margins of US rural and critical access hospitals have radically decreased, leaving these challenged institutions in a financially...

Virtua Health partners with care.ai for enterprise-wide implementation of AI-Enabled Virtual Care Solutions for Patients

Virtua Health will leverage care.ai's Smart Care Facility Platform and Always-Aware ambient sensors to enhance patient care, support nursing staff,...

Novel Randomized Control Trial Reveals Impact of Medisafe on Medication Self-Efficacy and Medication Adherence to Improve Health Outcomes in Medically Underserved Populations

BOSTON, MA / ACCESSWIRE / February 13, 2024 / A novel randomized control trial conducted by Vanderbilt University researchers and...

Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome

BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming...

Chiesi Global Rare Diseases Announces Health Canada Approval of MYALEPTA™ (metreleptin for injection) for the Treatment of Patients with Lipodystrophy

Canadian patients living with this ultra-rare condition welcome this new treatment optionBOSTON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Chiesi Global...

error: Content is protected !!